Related Experiment Videos
Gleason Grading, Biochemical Failure, and Prostate Cancer-Specific Death
1From the VA and Duke University Medical Centers, Durham, NC.
American Journal of Clinical Pathology
|April 11, 2017
Summary
The new Gleason grade groups effectively predict prostate cancer-specific mortality. These groups show a clear correlation with the probability of dying from prostate cancer, ranging from low to high risk.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Prostate cancer grading is crucial for prognosis.
- The Gleason score has been historically used but has limitations.
- Recently defined Gleason grade groups offer improved stratification.
Purpose of the Study:
- To investigate the association between the new Gleason grade groups and prostate cancer-specific mortality.
- To quantify the risk of prostate cancer death based on these new classifications.
Main Methods:
- Utilized probability theory to model prostate cancer-specific death (P(PSD)).
- Estimated P(PSD) using probabilities of biochemical failure (P(BF)) and death after failure (P(PSD | BF)).
- Applied literature data for P(PSD | BF) and P(BF) to calculate P(PSD) for each Gleason grade group.
Main Results:
- A direct relationship was observed between Gleason grade groups and prostate cancer-specific mortality.
- Estimated P(PSD) ranged from 0.014 for Gleason grade group 1 to 0.15 for Gleason grade group 5.
- The new grading system demonstrates a gradient of risk.
Conclusions:
- The newly defined Gleason grade groups are significantly related to prostate cancer-specific mortality.
- These groups provide valuable prognostic information for patient outcomes.
- Further long-term follow-up may refine these associations but current data is indicative.